Get started
Work

BMS-911543 inhibits viability of tumor and stromal cells and limits disease progression in genetically engineered mice with pancreatic cancer

Year: 2014
Type: article
Abstract: Meeting abstracts Pancreatic cancer (PCa) is resistant to cytotoxic therapies, and the profound immune suppressive nature of this disease renders patients non-responsive to immunologic therapies. Signaling downstream of IL-6 is important in the genesis and progression of PCa. The IL-6/Jak2/STAT3
DOI: 10.1186/2051-1426-2-s3-p186
Authors: Thomas Mace, Reena Shakya, Benjamin Swanson, Thomas Ludwig, Omar Elnaggar, Hannah Komar, Jennifer Yang, Gregory Young, Wendy Frankel, Peter Muscarella, Tanios Bekaii-Saab, Mark Bloomston, Gregory Lesinski
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: gold
Estimated APC paid: $2,490
OpenAlex ID: W2077533653
FWCI:
Cites:
Cited by:
Related to: 10